Evaluating the Efficacy of Intravenous Acetaminophen (IV Tylenol) in Reducing Pain and Agitation in Pediatric Patients Undergoing Elective Tonsillectomy and/or Adenoidectomy

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
MetroHealth Medical Center
Study ID
NCT07576985
Status
Enrolling By Invitation

Conditions

  • Adenoidectomy
  • Tonsillectomy

Eligibility Criteria

Sex
ALL
Age
N/A - 8 Years
Healthy Volunteers
Not accepted

Interventions

  • No Intervention: Observational Cohort — OTHER
    No Intervention: Observational Cohort

Study Details

MetroHealth's main campus administers IV Tylenol as part of its pain management protocol for elective tonsillectomy/adenoidectomy, whereas Parma campus does not. Comparing these practices provides an opportunity to evaluate the benefits of IV Tylenol for pain, agitation, and associated secondary outcomes in this population. The pain/agitation would be assessed with a validated tool PAED and FLACC

Key Dates

Start date
Apr 21, 2025
Status verified
May 2026
Primary completion
May 1, 2026
Completion
Aug 1, 2026

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Acetaminophen per os
    Patients who are administered Acetaminophen per os.
  • Arm: Intravenous Acetaminophen
    Patients who are administered Acetaminophen intravenously.

Primary Outcome Measure

Pain Assessment [ Time Frame: * "Baseline" * "Perioperative/Periprocedural" ]

Locations (1)

FacilityCityStateZIPSite coordinators
MetroHealth Medical CenterClevelandOhio44109-1997-

Find similar trials in Cleveland, OH

By research site
MetroHealth Medical Center· Cleveland, OH

Related Studies